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ABSTRACT
Physiological range upper and lower limit values are the reference to consider normal in any state of medical parameter. To address blood glucose or 
blood pressure value reaching upper limits of normal so called high normal or borderline a new term is introduced called as predisease, the concept of 
predisease is relatively new like addressing prediabetes or prehypertension which do pose health risk and might be a sign of warning that a patient is 
progressing toward overt hypertension or diabetes. This short paper focuses on the concept of prediabetes and its definition along with its historical 
perspective.
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HISTORICAL PERSPECTIVE
Concept of prediabetes was on discussion since 1950 but it remained 
only in talk till 2000, and in 2003, the diagnostic criteria to demarcate 
diabetes and prediabetes came into use. But before, WHO in 1980 put 
forward a classification of diabetes on the basis of statistically significant 
risk groups who are more prone to develop diabetes in the near future. 
In 1979, the WHO officially introduced the term glucose tolerance test 
(GTT) with an extra categorical type in which patient do have alteration 
and imbalance in glucose metabolism that later included as impaired 
fasting glucose (IFG) [1].
DEFINITION OF PREDIABETES
Definition of prediabetes includes the concept visualizing of IFG 
and impaired glucose tolerance value made after 11 years follow-
up study report by Wen et al. in this context IFG between 6.1 and 6.9 
mmol/L (100-125 mg/dL) had significantly hiked rate of mortality 
due to cardiovascular disease (CVD) compared to people with less 
than IFG 6 mmol/L [2].
Review by Unwin and colleagues concluded that IFG and IGT 
(glucose ≥7.8 and <11.1 mmol/L (140-199 mg/dL) 2 hrs after ingestion 
of a 75-g oral glucose load IGT impaired glucose tolerance) has a more 
strong association with CVD than IFG was [3].
The American Diabetes Association (ADA) defined prediabetes by 
taking the scope of diabetes, a continuum of hyperglycemia that 
has role in microvascular and macrovascular complication thus to 
preclude or prevent such complexes certain measure or methods are 
recommended to delay the progression of prediabetes to diabetes. 
An ADA panel revised Type 2 diagnostic criteria introducing IFG level 
100-125 mg/dl and these people who show IFG though it is different 
sort of glucose intolerance risk to develop Type 2 diabetes is also 
present  in  these  group  [4,5]  suggesting  that  targeting  to  a  specific 
risk group patient metformin therapy can be prescribed otherwise 
in normal status nonpharmacological intervention such as lifestyle 
modification need to be adopted.
Both IGT and IFG are designated as “prediabetes” because of its slow 
pace toward Type 2 diabetes mellitus (DM) in the near future. Nearly 70 




in blood pool over the past 2-3 months) [7].
Fasting blood glucose of 100-125 mg/dl.
An oral GTT 2 hrs blood glucose of 140 mg/dl-199 mg/dl.
CONCLUSION
A concept of transition phase IFG and IGT devised known as prediabetes 
a form of normal glucose tolerance before demonstration of overt Type 2 
diabetes was described as impaired glucose tolerance that is second half 
plasma glucose level between 140 and 199 mg/dl this stage possess the 
highest risk for diabetes in near future of life. Since prediabetes can cause 
highest prevalence risk of Type 2 diabetes leading to hiking mortality, 
morbidity, and health-care costs hence it is accepted as an important public 
threatening ailment. Thus, understanding the concept of prediabetes 
is compulsion among all individuals and alleviating its processing 
phenomenon from IGT and/or IFG to overt Type 2 DM is necessary that 
will help to combat its epidemic and lessen health-care cost.
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